Patent · US Active

Heterocyclic compound and use thereof

US11440883B2 · kind B2 · utility

1Cited by
5References
1Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 6, 2020
Grant dateSep 13, 2022
Priority date—
Expiry dateAug 31, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D417/14
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention provides a heterocyclic compound having an orexin type 2 receptor agonist activity.A compound represented by the formula (I):

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.